[1]Saltiel AR. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes[J]. Cell, 2001, 104: 517-529. [2]Liang W, Li X, Li G, et al. Sirt1/Foxo axis plays a crucial role in the mechanisms of therapeutic effects of Erzhi Pill in ovariectomized rats[J]. Evid Based Complement Alternat Med, 2018, 2018: 9210490. doi:10.1155/2018/9210490. [3]杨珣,苏东明.HRD1在肝脏糖异生中的作用[J].江苏医药,2017,43:908-911. [4]Geng C, Xue Y, Yang JH, et al. SIRT1 mediates sestrin1-induced improvement in hepatic insulin resistance[J]. Biomed Environ Sci, 2022, 35: 79-83. [5]Matsumoto M, Ogawa W, Teshigawara K, et al. Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucoki-nase genes in rat hepatocytes[J]. Diabetes, 2002, 51: 1672-1680. [6]Wang Z, Dong C. Gluconeogenesis in cancer: function and regulation of PEPCK, FBPase, and G6Pase[J]. Trends Cancer, 2019, 5: 30-45. [7]Kim JS, Ro SH, Kim M, et al. Sestrin2 inhibits mTORC1 through modulation of GATOR complexes[J]. Sci Rep, 2015, 5: 9502. doi:10.1038/srep09502. [8]Lee JH, Budanov AV, Talukdar S, et al. Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3[J]. Cell Metab,2012, 16: 311-321. [9]Piccinin E, Villani G, Moschetta A. Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators[J]. Nat Rev Gastroenterol Hepatol, 2019, 16: 160-174. [10]Rada P, Pardo V, Mobasher MA, et al. SIRT1 controls acetaminophen hepatotoxicity by modulating inflammation and oxidative stress[J]. Antioxid Redox Signal, 2018;28:1187-1208. |